We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




IT Certification Program Simplifies Patient-Specific Simulation

By MedImaging International staff writers
Posted on 12 Sep 2012
Print article
New technology allows clinicians to rapidly, and as part of their operative preplanning, create virtual patient cases, on which realistic procedures can be practiced in a safe, simulated environment.

Mentice (Gothenburg, Sweden), a leader in medical cardiovascular and endovascular simulation, announced that Pie Medical Imaging (Maastricht, the Netherlands) will be the first company to join its VIST Case-It “Segmentation to Simulation” certification program.

VIST Case-It lets users of Mentice’s VIST range of high-fidelity full-physics simulators easily import anatomy data from real patients to a simulator, using professional computed tomography/magnetic resonance imaging (CT/MRI) segmentation tools and standard hospital workflows.

To ensure flawless workflow integration and operation between third-party segmentation solutions and the VIST medical simulators, Mentice has launched an open certification program for validating compatibility with the VIST Case-It technology. Pie Medical Imaging is the first company to obtain this certification for their 3mensio Vascular segmentation suite and can now under the certification program offer verified compatibility with Mentice’s VIST simulators.

“In the future we will undoubtedly continue to see medical simulation becoming more directly integrated into existing hospital workflows. With our exciting new VIST Case-It technology, physicians have the ability to themselves create patient-specific simulated cases using the industry standard segmentation tools they are already familiar with. We are extremely pleased to welcome Pie Medical Imaging to our certification program, their products are some of the most innovative and appreciated on the market and are a perfect match for this technology,” stated Göran Malmberg, CEO of Mentice.

René Guillaume, director of sales and marketing at Pie Medical Imaging, “We are proud to be the first to offer verified compatibility of our product to Mentice’s customers. Our 3mensio Vascular suite is essential for patient-specific planning of endovascular procedures. Using both 3mensio Vascular and Mentice’s VIST will ensure every physician to be fully prepared for every procedure with the most advanced technologies.”

Mentice will be presenting the VIST Case-It technology at the CIRSE congress in Lisbon (Portugal) from September 14-19, 2012.

Related Links:
Mentice
Pie Medical Imaging

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Fixed X-Ray System (RAD)
Allengers 325 - 525
Ultrasound Color LCD
U156W
New
DRF DR & Remote Fluoroscopy Solution
CombiDiagnost R90

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: Artificial intelligence models can be trained to distinguish brain tumors from healthy tissue (Photo courtesy of 123RF)

AI Can Distinguish Brain Tumors from Healthy Tissue

Researchers have made significant advancements in artificial intelligence (AI) for medical applications. AI holds particular promise in radiology, where delays in processing medical images can often postpone... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.